3billion Signs 900 Million KRW Newborn Genomic Screening Consignment Contract with Asan Medical Center

3billion has entered into a consignment contract with Asan Medical Center for K-gNBS newborn genomic screening based on whole genome sequencing.
The contract is valued at 900 million KRW, representing 7.69% of 2025 annual revenue of 11.7 billion KRW, with a term from June 2026 to December 2028.
This agreement is expected to generate new revenue streams and strengthen collaboration with a leading medical institution, positively impacting growth prospects.
Payment terms are monthly billing after testing completion with payment in the following month, minimizing cash flow burden.
[AI Summary]3billion secured a newborn genomic screening contract with top-tier Asan Medical Center, diversifying revenue and enhancing credibility. The contract size of 7.69% of revenue is meaningful and could lead to additional contracts, serving as a medium to long-term positive factor for the stock price.